Vpriv Injection, Powder, Lyophilized, For Solution
Product Images NDC 54092-701

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Vpriv (NDC 54092-701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Vpriv 01

Vpriv 01
Carton packaging for VPRIV (velaglucerase alfa) injection powder, lyophilized, for solution, 400 units/vial. The box displays dosing instructions, storage conditions (2°C to 8°C), and the labeler Takeda Pharmaceuticals America, Inc. Contact information and barcode are also visible. The product is for intravenous use and labeled Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.